{
  "pmcid": "12369437",
  "sha256": "c2e1d064b62f4aa30bd57bcaba45b779d98f2e97f8bb40909d98d5850da63f50",
  "timestamp_utc": "2025-11-09T22:23:26.336249+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.786252615062761,
    "reading_ease": 22.827412395397516,
    "word_count": 239
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial on Seroma Management after Groin Surgery"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomly assigned to either the intervention group, receiving LigaSure electrothermal bipolar sealing device, or the control group, receiving conventional techniques."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were patients undergoing groin surgery, with eligibility criteria including age over 18 and no prior groin surgeries. The study was conducted in a tertiary care hospital."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomly assigned to either the intervention group, receiving LigaSure electrothermal bipolar sealing device, or the control group, receiving conventional techniques."
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial was conducted to evaluate seroma management strategies."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the incidence of seroma formation within 30 days post-surgery."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised, with 100 in each group, between January 2020 and June 2021."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted on an intention-to-treat basis, with 98 participants in the intervention group and 97 in the control group."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "In the intervention group, the seroma incidence was significantly reduced (mean difference = 12%, 95% CI 5% to 19%; p = 0.002)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were reported in 3% of the intervention group and 1% of the control group, with mild severity."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: N/A"
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: None."
      }
    },
    "total_score": 21,
    "max_score": 25
  }
}